HOME
>
臨床医学：内科
>
脳神経科学/神経内科学
> 識る　診る　治す　頭痛のすべて

識る　診る　治す　頭痛のすべて

出版社：	中山書店
著者：	辻省次(シリーズ総編集) 鈴木則宏(専門編集)
発行日：	2011-11-25
分野：	臨床医学：内科 > 脳神経科学/神経内科学
ISBN：	9784521734385
電子書籍版：	2011-11-25 （初版第2刷）

書籍・雑誌

≪全国送料無料でお届け≫

取寄せ目安：8～14営業日

10,450 円(税込)

購入する

電子書籍

章別単位で購入

ブラウザ、アプリ閲覧

10,450 円(税込)

購入する

商品紹介

頭痛は，神経内科のみならず一般・総合内科や救急医学においても極めて重要であるが，一般的であるがゆえに最もアプローチしにくい症候ともいえる。本書は頭痛診療現場の第一線で活躍中の執筆陣により，神経内科医に必要な知識を包括的にまとめたもので，巻末付録には国際頭痛分類第2版による診断基準や，頭痛の治療・予防に用いられる薬剤一覧などを掲載。頭痛の実地診療にいますぐ役立つ一冊である。

目次

識る　診る　治す　頭痛のすべて

―目次―

I．頭痛のアウトライン
II．頭痛診療のポイント
III．片頭痛
IV．緊張型頭痛
V．群発頭痛
VI．薬物乱用頭痛，慢性連日性頭痛
VII．小児・思春期の頭痛
VIII．その他の一次性頭痛
IX．頭部神経痛および中枢性顔面痛
Case Study

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I. 頭痛のアウトライン

P.7 掲載の参考文献

1) Headache Classification of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 ; 8 (Suppl 7) : 1-96.

2) Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004 ; 24 (Suppl 1) : 1-160.

3) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

4) Sakai F, Igarashi H. Prevalence of migraine in Japan : A nationwide survey. Cephalalgia 1997 ; 17 : 15-22.

5) Takeshima T, et al. Population-based door-to-door survey of migraine in Japan : The Daisen study. Headache 2004 ; 44 : 8-19.

6) Robbins MS, Lipton RB. The epidemiology of primary headache disorders. Semin Neurol 2010 ; 30 : 107-119.

7) Solomon GD, et al. Does quality of life differ among headache diagnoses? Analysis using the medical outcomes study instrument. Headache 1994 ; 34 : 143-147.

8) 五十嵐久佳ほか. 群発頭痛の予後. 頭痛研究会会誌 1996 ; 23 : 24-26.

9) Imai N, et al. Clinical profile of cluster headaches in Japan : Low prevalence of chronic cluster headache, and uncoupling of sense and behavior of restlessness. Cephalalgia 2011 ; 31 : 628-633.

10) Manzoni GC. Gender ratio of cluster headache over the years : A possible role of changes in lifestyle. Cephalalgia 1998 ; 18 : 138-142.

11) Tepper SJ, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache : Data from the landmark study. Headache 2004 ; 44 : 856-864.

12) Tatsuoka Y. Headache in a Japanese secondary care setting : Comparison with diagnosis prior to attendance and analysis of referral pathway. Headache Care 2005 ; 2 : 145-149.

13) Igarashi H, Sakai F. Current status of diagnosis and treatment of migraine headache in Japanese women. Headache Care 2004 ; 1 : 207-213.

P.14 掲載の参考文献

1) Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders ; 2nd edition. Cephalalgia 2004 ; 24 (Supple 1) : 1-160.

2) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

3) Olessen J, Lipton RB. Migraine classification and diagnosis. International Headache Society Criteria. Neurology 1994 ; 44 (6 Suppl 4) : S6-10.

4) 五十嵐久佳. 頭痛の疫学. Clinical Neuroscience 2007 ; 25 (5) : 516-518.

5) Rassmussen BK, Olessen J. Migraine with aura and migraine without aura : An epidemiological study. Cephalalgia 1992 ; 12 : 221-228.

6) Evans RW, Tietjen GE. Migrainous aura versus transient ischemic attack in an elderly migraineur. Headache 2001 ; 41 : 201-203.

7) Ducros A, et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neurol calcium channel. N Engl J Med 2001 ; 345 : 17-24.

8) Bigal ME, et al. Chronic daily headache in a tertiary care population : Correlation between the International Headache Society diagnostic criteria and proposed revisions of criterita for chronic daily headache. Cephalalgia 2002 ; 22 : 432-438.

9) Cohen AS, et al. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA). A prospective clinical study of SUNCT and SUNA. Brain 2006 ; 129 : 2746-2760.

10) Koopman K, et al. An often unrecognized cause of thunderclap headache : Reversible cerebral vasoconstriction syndrome. J Headache Pain 2008 ; 9 : 389-391.

P.26 掲載の参考文献

1) Olesen J, et al. Origin of pain in migraine : Evidence for peripheral sensitisation. Lancet Neurol 2009 ; 8 : 679-690.

2) WolffHG. Headache and Other Head Pain. New York : Oxford University Press ; 1963.

3) Goadsby PJ, et al. Migraine--current understanding and treatment. N Engl J Med 2002 ; 346 : 257-270.

4) Weiller C, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995 ; 1 : 658-660.

5) Bahra A, et al. Brainstem activation specific to migraine headache. Lancet 2001 ; 357 : 1016-1017.

6) Afridi SK, et al. A positron emission tomographic study in spontaneous migraine. Arch Neurol 2005 ; 62 : 1270-1275.

7) Cao Y, et al. Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol 1999 ; 56 : 548-554.

8) Hadjikhani N, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 2001 ; 98 : 4687-4692.

9) Burstein R, et al. An association between migraine and cutaneous allodynia. Ann Neurol 2000 ; 47 : 614-624.

10) Burstein R, et al. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000 ; 123 : 1703-1709.

11) Head pain and associated symptoms. In : DavidoffRA (editor). Migraine Manifestations, Pathogenesis, and Management, 2nd edition. Contemporary Neurology Series. New York : Oxford University Press ; 2002, pp. 228-273.

12) Ray BS, WolffHG. Experimental studies on headache : Pain sensitive structures of the head and their significance in headache. Arch Surg 1940 ; 41 : 813-856.

13) Nichols FT 3rd, et al. Focal headache during balloon inflation in the internal carotid and middle cerebral arteries. Stroke 1990 ; 21 : 555-559.

14) Brennan KC, Charles A. An update on the blood vessel in migraine. Curr Opin Neurol 2010 ; 23 : 266-274.

15) Messlinger K, et al. Anatomy and Physiology of Head Pain. In : Olesen J, et al (editors), The Headaches, 3rd edition. Philadelphia : Lippincott Williams & Wilkins ; 2006, pp. 95-109.

16) May A, Goadsby PJ. The trigeminovascular system in humans : Pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 1999 ; 19 : 115-127.

17) Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984 ; 16 : 157-168.

18) Raskin NH, et al. Headache may arise from perturbation of brain. Headache 1987 ; 27 : 416-420.

19) Knight YE, Goadsby PJ. The periaqueductal grey matter modulates trigeminovascular input : A role in migraine? Neuroscience 2001 ; 106 : 793-800.

20) Knight YE, et al. P/Q-type calcium-channel blockade in the periaqueductal gray facilitates trigeminal nociception : A functional genetic link for migraine? J Neurosci 2002 ; 22 : RC213.

● Messlinger K. Migraine : Where and how does the pain originate? Exp Brain Res 2009 ; 196 : 179-193.

P.32 掲載の参考文献

1) Ogawa S, et al. Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. Biophys J 1993 ; 64 (3) : 803-812.

2) Kobari M, et al. Cortical and subcortical hyperperfusion during migraine and cluster headache measured by Xe CT-CBF. Neuroradiology 1990 ; 32 (1) : 4-11.

3) De Benedittis G, et al. CBF changes during headache-free periods and spontaneous/induced attacks in migraine with and without aura : A TCD and SPECT comparison study. J Neurosurg Sci 1999 ; 43 (2) : 141-146 ; discussion 6-7.

4) Coghill RC, et al. Pain intensity processing within the human brain : A bilateral, distributed mechanism. J Neurophysiol 1999 ; 82 (4) : 1934-1943.

5) Goadsby PJ, May A. PET demonstration of hypothalamic activation in cluster headache. Neurology 1999 ; 52 (7) : 1522. http://www.neurology.org/content/52/7/1522.full

6) Weiller C, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995 ; 1 (7) : 658-660.

7) 濱田潤一. 片頭痛の病態生理-generatorを中心に. 臨床神経学 2008 ; 48 (11) : 857-860.

8) Bahra A, et al. Brainstem activation specific to migraine headache. Lancet 2001 ; 357 (9261) : 1016-1017.

9) Cutrer FM, et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 1998 ; 43 (1) : 25-31.

10) Lauritzen M, et al. Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol 1983 ; 13 (6) : 633-641.

11) Sanchez del Rio M, et al. Perfusion weighted imaging during migraine : Spontaneous visual aura and headache. Cephalalgia 1999 ; 19 (8) : 701-707.

12) Woods RP, et al. Brief report : Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994 ; 331 (25) : 1689-1692.

13) Hadjikhani N, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 2001 ; 98 (8) : 4687-4692.

14) Takano T, et al. Cortical spreading depression causes and coincides with tissue hypoxia. Nat Neurosci 2007 ; 10 (6) : 754-762.

15) Latour LL, et al. Spreading waves of decreased diffusion coefficient after cortical stimulation in the rat brain. Magn Reson Med 1994 ; 32 (2) : 189-198.

● Tfelt-Hansen PC, Koehler PJ. One hundred years of migraine research : Major clinical and scientific observations from 1910 to 2010. Headache 2011 ; 51 (5) : 752-778.

II. 頭痛診療のポイント

P.40 掲載の参考文献

1) Purdy RA. Clinical evaluation of a patient presenting with headache. Med Clin North Am 2001 ; 85 (4) : 847-863.

2) McConaghy JR. Headache in primary care. Prim Care 2007 ; 34 : 83-97.

3) Swadron SP. Pitfalls in the management of headache in the emergency department. Emerg Med Clin North Am 2010 ; 28 : 127-147.

4) 濱田潤一. 内科コモンプロブレム頭痛. Medicina 2004 ; 41 (4) : 592-596.

P.50 掲載の参考文献

1) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

2) 厚生労働科学研究費補助金, 片頭痛の具体的な医療手順に関する調査研究, 平成15年度総括・分担研究報告. 2004年3月.

3) Sakai F, et al. Prevalence of migraine in Japan : A nationwide survey. Cephalalgia 1997 ; 17 : 15-22.

4) Lipton RB, et al. Migraine in the United States : Epidemiology and patterns of health care use. Neurology 2002 ; 58 : 885-894.

5) Stewart WF, et al. Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration. Neurology 1994 ; 44 (Suppl 4) : S24-S39.

6) Hu XH, et al. Burden of migraine in the United States : Disability and economic costs. Arch Intern Med 1999 ; 159 : 813-815.

7) Lipton RB, et al. Prevalence and burden of migraine in the United States : Data from the American Migraine Study II. Headache 2001 ; 41 : 646-657.

8) Diener HC, Limmorth V. Medication-overuse headache : A worldwide problem. Lancet Neurol 2004 ; 3 : 475-483.

9) Silberstein SD. Practice parameter : Evidence-based guidelines for migraine headache (an evidence-based review) : Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000 ; 55 : 754-762.

10) Lipton RB, et al. A self-administered screener for migraine in primary care. The ID Migraine validation study. Neurology 2003 ; 61 : 375-382.

11) 坂井文彦. 診療アシストパッケージの活用. 片頭痛の具体的な医療手順に関する調査研究平成15年度研究報告書. 2004, pp.59-65.

12) 平田幸一. 頭痛診療における問診の重要性と診療コミュニケーションツール. Medicina 2006 ; 43 : 1816-1819.

13) 日本頭痛学会 (編). 慢性頭痛の診療ガイドライン. 東京 : 医学書院 ; 2006.

14) 今井昇ほか. 片頭痛と緊張型頭痛の診断における頭痛チェックシートの有用性の検討. 静岡赤十字病院研究報 2002 ; 22 (1) : 1-4.

15) Williams P, et al. The cost effectiveness of stratified care in the management of migraine. Pharmacoeconomics 2001 ; 19 : 819-829.

16) Lipton RB, et al. Stratified care vs step care strategies for migraine. The DIsability in Strategies of Care (DISC) Study : A randomized trial. JAMA 2000 ; 284 : 2599-2605.

17) Stewart WF, et al. Reliability of the migraine disability assessment score in a population-based sample of headache sufferes. Cephalalgia 1999 ; 19 : 107-114.

18) Iigaya M, et al. Reliability and validity of the Japanese Migraine Assessmet (MIDAS) Questionnaire. Headache 2003 ; 43 : 343-352.

19) Kosinski M, et al. A six-item short-form survey for measuring headache impact : The HIT-6. Qual Life Res 2003 ; 12 : 963-974.

20) Takeuchi A, et al. Development of a comprehensive medical recorder on a cellphone. Comput Methods Programs Biomed 2010 ; 97 (1) : 28-38. Epub 2009 Jun 11

P.62 掲載の参考文献

1) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

2) 日本頭痛学会 (編). 慢性頭痛の診療ガイドライン. 東京 : 医学書院 ; 2006.

P.71 掲載の参考文献

1) 濱田潤一. 内科コモンプロブレム頭痛. Medicina 2004 ; 41 : 592-596.

2) 日本頭痛学会 (編). 慢性頭痛の診療ガイドライン. 東京 : 医学書院 ; 2006.

3) Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004 ; 24 (Suppl 1) : 9-160.

4) 濱田潤一. 頭痛診療と診療アルゴリズム. 鈴木則宏 (編), 頭痛診療ハンドブック. 東京 : 中外医学社 ; 2009, pp.23-30.

5) Evans RW. Diagnostic testing for migraine and other primary headaches. Neurol Clin 2009 ; 27 : 393-415.

6) Dowson AJ, et al. Establishing principles for migraine management in primary care. Int J Clin Pract 2003 ; 57 : 493-507.

7) Detsky ME, et al. Does this patient with headache have a migraine or need neuroimaging? JAMA 2006 ; 296 : 1274-1283.

8) 北川泰久. 頭痛の診断と鑑別. 臨床と研究 2007 ; 84 : 1167-1173.

9) Dodick DW. Clinical clues (primary/secondary), The 14th Migraine Trust International Symposium. London, 2002.

10) Pryse-Phillips W, et al. A headache diagnosis project. Headache 2002 ; 42 : 728-737.

11) Lipton RB, Bigal ME (editors). Migraine and Other Headache Disorders. New York : Informa Health Care ; 2006.

III. 片頭痛

P.83 掲載の参考文献

1) Lance JW, et al. 5-Hydroxytryptamine and its putative aetiological involvement in migraine. Cephalalgia 1989 ; 9 (Suppl 9) : 7-13.

2) Takeshima T, et al. Muscle contraction headache and migraine. Platelet activation and plasma norepinephrine during the cold pressor test. Cephalalgia 1989 ; 9 (1) : 7-13.

3) Olesen J, et al. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981 ; 9 (4) : 344-352.

4) Moskowitz MA, Macfarlane R. Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc Brain Metab Rev 1993 ; 5 (3) : 159-177.

5) 竹島多賀夫ほか. 痛覚受容の促進と抑制・疼痛感作とアロディニア. Clinical Neuroscience 2007 ; 25 (5) : 532-535.

6) Hadjikhani N, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 2001 ; 98 (8) : 4687-4692.

7) Bousser MG, Welch KM. Relation between migraine and stroke. Lancet Neurol 2005 ; 4 (9) : 533-542.

8) Kruit MC, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004 ; 291 (4) : 427-434.

9) Nozari A, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol 2010 ; 67 (2) : 221-229.

10) Bolay H, et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002 ; 8 (2) : 136-142.

11) Gursoy-Ozdemir Y, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 2004 ; 113 (10) : 1447-1455.

12) Imamura K, et al. Increased plasma matrix metalloproteinase-9 levels in migraineurs. Headache 2008 ; 48 (1) : 135-139.

13) Russell MB, et al. Migraine without aura and migraine with aura are inherited disorders. Cephalalgia 1996 ; 16 (5) : 305-309.

14) 竹島多賀夫ほか. 片麻痺性片頭痛. 神経内科 2007 ; 66 (3) : 244-251.

15) Kowa H, et al. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000 ; 96 (6) : 762-764.

16) 竹島多賀夫. 頭痛と遺伝子. ModernPhysician 2011 ; 31 (8) : 937-941.

17) Weiller C, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995 ; 1 (7) : 658-660.

18) Takeshima T, et al. Acrophase amplitude of ambulatory blood pressure decreases in migraineurs. Headache 1997 ; 37 (9) : 577-582.

19) 竹島多賀夫. 片頭痛におけるCortical Spreading Depression (CSD). 日本頭痛学会誌 2011 ; 38 (1) : 50-55

● Goadsby PJ, et al. Migraine--current understanding and treatment. N Engl J Med 2002 ; 346 (4) : 257-270.

● Wessman M, et al. Migraine : A complex genetic disorder. Lancet Neurol 2007 ; 6 : 521-532.

● Dalkara T, et al. Migraine aura pathophysiology : The role of blood vessels and microembolisation. Lancet Neurol 2010 ; 9 : 309-317.

P.89 掲載の参考文献

1) Rapport MM, et al. Serum vasoconstrictor, serotonin : Isolation and characterization. J Biol Chem 1948 ; 176 : 1243-1251.

2) 横山光宏. 「セロトニンとセロトニン受容体」最近の話題. 横山光宏 (編). 循環器領域におけるセロトニン研究の新たな展開. 東京 : メディカルレビュー社 ; 2002, pp.1-9.

3) Goadsby PJ. The pharmacology of headache. Prog Neurobiol 2000 ; 62 : 509-525.

4) Gupta S, et al. Chemical mediators of migraine : Preclinical and clinical observations. Headache 2011 ; 51 : 1029-1045.

5) 古和久典, 中島健二. 片頭痛. 横山光宏 (編). 循環器領域におけるセロトニン研究の新たな展開. 東京 : メディカルレビュー社 ; 2002, pp.142-152.

6) Peroutka SJ. Dopamine and migraine. Neurology 1997 ; 49 : 650-656.

7) Blin O, et al. Apomorphine-induced yawning in migraine patients : Enhanced responsiveness. Clinical Neuropharmacology 1991 ; 14 : 91-95.

8) Del Bene E, et al. Video assessment of yawning induced by sublingual apomorphine in migraine. Headache 1994 ; 34 : 536-538.

9) Bates D, et al. Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura Study Group. Neurology 1994 ; 44 : 1587-1592.

10) Waelkens J. Dopamine blockade with domperidone : Bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia 1984 ; 4 : 85-90.

11) Leao AA. Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944 ; 7 : 359-390.

12) Leao AA. Pial circulation and spreading depression of activity in the cerebral cortex. J Neurophysiol 1944 ; 7 : 391-396.

13) Martins-Ferreira H, et al. Perspectives on spreading depression. Brain Res Rev 2000 ; 32 : 215-234.

14) Gorji A. Spreading depression : A review of the clinical relevance. Brain Res Rev 2001 ; 38 : 33-60.

15) Calabresi P, et al. Antiepileptic drugs in migraine : From clinical aspects to cellular mechanisms. Trends Pharmacol Sci 2007 ; 28 : 188-195.

16) Welch KM, et al. Cerebrospinal fluid gamma aminobutyric acid levels in migraine. Br Med J 1975 ; 3 : 516-517.

17) Amara SG, et al. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 1982 ; 298 : 240-244.

18) Recober A, et al. Role of calcitonin gene-related peptide in light-aversive behavior : Implications for migraine. J Neurosci 2009 ; 29 : 8798-8804.

19) Williamson DJ, et al. Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia 1997 ; 17 : 518-524.

20) Akerman S, et al. Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicininduced dural dilation. Br J Pharmacol 2003 ; 140 : 718-724.

21) Wahl M, et al. Involvement of calcitonin-gene-related peptide (CGRP) and nitric-oxide (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Res 1994 ; 637 : 204-210.

22) Le Greves P, et al. Calcitonin gene-related peptide is a potent inhibitor of substance P degradation. Eur J Pharmacol 1985 ; 115 : 309-311.

23) Fusayasu E, et al. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 2007 ; 128 : 209-214.

24) Goldstein DJ, et al. Ineffectiveness of neurokinin-1 antagonist in acute migraine : A crossover study. Cephalalgia 1997 ; 17 : 785-790.

25) Goldstein D, et al. Lanepitant, an NK-1 antagonist, in migraine prevention. Cephalalgia 2001 ; 21 : 102-106.

26) Greco R, et al. Role of calcitonin gene-related peptide and substance P in different models of pain. Cephalalgia 2008 ; 28 : 114-126.

● 清水利彦ほか. 片頭痛の病態研究および治療に関する最近の知見. 臨床神経学 2011 ; 51 : 103-109.

● Gupta S, et al. Chemical mediators of migraine : Preclinical and clinical observations. Headache 2011 ; 51 : 1029-1045.

P.98 掲載の参考文献

1) Russell MB, Ducros A. Sporadic and familial hemiplegic migraine : Pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 2011 ; 10 : 457-470.

2) Thomsen LL, et al. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 2002 ; 125 : 1379-1391.

3) Ducros A, et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 2001 ; 345 : 17-24.

4) OphoffRA, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996 ; 87 : 543-552.

5) De Fusco M, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003 ; 33 : 192-196.

6) Dichgans M, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005 ; 366 : 371-377.

7) Riant F, et al. De novo mutations in ATP1A2 and CACNA1A are frequent in earlyonset sporadic hemiplegic migraine. Neurology 2010 ; 75 : 967-972.

8) Wessman M, et al. Migraine : A complex genetic disorder. Lancet Neurol 2007 ; 6 : 521-532.

9) de Vries B, et al. Molecular genetics of migraine. Hum Genet 2009 ; 126 : 115-132.

10) van den Maagdenberg AM, et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 2004 ; 41 : 701-710.

11) Jen JC, et al. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 2005 ; 65 : 529-534.

12) Suzuki M, et al. Defective membrane expression of the Na (+) -HCO (3) (-) cotransporter NBCe1 is associated with familial migraine. Proc Natl Acad Sci U S A 2010 ; 107 : 15963-15968.

13) Liem MK, et al. CADASIL and migraine : A narrative review. Cephalalgia 2010 ; 30 : 1284-1289.

14) Richards A, et al. C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet 2007 ; 39 : 1068-1070.

15) Marziniak M, et al. An association of migraine with hereditary haemorrhagic telangiectasia independently of pulmonary right-to-left shunts. Cephalalgia 2009 ; 29 : 76-81.

16) Finsterer J. Central nervous system manifestations of mitochondrial disorders. Acta Neurol Scand 2006 ; 114 : 217-238.

17) Colson N, et al. The search for migraine genes : An overview of current knowledge. Cell Mol Life Sci 2007 ; 64 : 331-344.

18) Samaan Z, et al. Methylenetetrahydrofolate Reductase Gene Variant (MTHFR C677T) and Migraine : A Case Control Study and Meta-analysis. BMC Neurol 2011 ; 11 : 66.

19) Liu H, et al. Association of 5-HTT gene polymorphisms with migraine : A systematic review and meta-analysis. J Neurol Sci 2011 ; 305 : 57-66.

20) Chasman DI, et al. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet 2011 ; 43 (7) : 695-698. advance online publication.

P.102 掲載の参考文献

1) Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders : 2nd edition. Cephalalgia 2004 ; 24 (Suppl 1) : 9-160.

2) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

3) Siberstein SD, et al. Classification of daily and near-daily headaches : Proposed revisions to the IHS criteria. Headache 1994 ; 34 : 1-7.

P.106 掲載の参考文献

1) Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders : 2nd edition. Cephalalgia 2004 ; 24 (Suppl 1) : 9-160.

2) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

3) Zagami AS, Bahra A. Symptomatology of migraines without aura. In : Olesen J, et al (editors), The Headache, 3rd edition. Philadelphia : Lippincott Williams & Wilkins ; 2006, pp.399-406.

4) Rasmussen BK. Migraine and tension-type headache in a general population : Precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 1993 ; 53 : 65-72.

5) Blau JN. Migraine : Theories of pathogenesis. Lancet 1992 ; 339 (8803) : 1202-1207.

P.112 掲載の参考文献

1) Zagami AS, Bahra A. Symptomatology of migraines without aura. In : J Olesen, et al (editors), The Headache, 3rd edition. Philadelphia : Lippincott Williams & Wilkins ; 2006, pp.399-406.

2) Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders : 2nd edition. Cephalalgia 2004 ; 24 (Suppl 1) : 9-160.

3) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

P.121 掲載の参考文献

1) 日本頭痛学会 (編). 慢性頭痛の診療ガイドライン. 東京 : 医学書院 ; 2006.

2) The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. Eur Neurol 1991 ; 31 : 314-322.

3) Sicuteri F, et al. Biochemical investigations in headache : Increase in hydroxyindoleacetic acid excretion during migraine attacks. Int Arch Allergy 1961 ; 19 : 55-58.

4) Humphrey PP, et al. GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br J Pharmacol 1988 ; 94 : 1123-1132.

5) Tepper SJ, Cleves C. Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine. Curr Opin Investig Drugs 2009 ; 10 : 711-720.

6) Ayata C, et al. Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 2006 ; 59 : 652-661.

7) Hauge AW, et al. Effects of tonabersat on migraine with aura : A randomised, doubleblind, placebo-controlled crossover study. Lancet Neurol 2009 ; 8 : 718-723.

● Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol 2010 ; 9 : 285-298.

P.124 掲載の参考文献

1) 日本頭痛学会 (編). 慢性頭痛の診療ガイドライン. 東京 : 医学書院 ; 2006.

2) Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol 2010 ; 9 : 285-298.

3) 嶋田豊. 頭痛と釣藤散, 葛根湯, 呉茱萸湯, 桂枝人参湯, 九味檳榔湯, 川弓茶調散. 寺澤捷年ほか (編), EBM 漢方, 第2版. 東京 : 医歯薬出版 ; 2007, pp.207-215.

P.131 掲載の参考文献

1) Sakai F, Igarashi H. Prevalence of migraine in Japan : A nationwide survey. Cephalalgia 1997 ; 17 : 15-22.

2) Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004 ; 24 (Suppl 1) : 9-160.

3) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

4) 五十嵐久佳. 女性の頭痛 (月経時片頭痛の診断・治療, 妊娠・授乳中の頭痛治療). 鈴木則宏 (編), 頭痛診療ハンドブック. 東京 : 中外医学社 ; 2009, pp.237-247.

5) Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972 ; 22 : 355-365.

6) Somerville BW. The role of progesterone in menstrual migraine. Neurology 1971 ; 21 : 853-859.

7) Martin VT, Behbehani M. Ovarian hormones and migraine headache : Understanding mechanisms and pathogenesis-part 1. Headache 2006 ; 46 : 3-23.

8) Parantainen J, et al. Relevance of prostaglandins in migraine. Cephalalgia 1985 ; 5 (Supple 2) : 93-97.

9) Mauskop A, et al. Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine. Headache 2002 ; 42 : 242-248.

10) 日本頭痛学会 (編). 慢性頭痛の診療ガイドライン. 東京 : 医学書院 ; 2006.

11) Pringsheim T, et al. Acute treatment and prevention of menstrually related migraine headache : Evidence-based review. Neurology 2008 ; 70 : 1555-1563.

12) Loder E, et al. Hormonal management of migraine associated with menses and the menopause : A clinical review. Headache 2007 ; 47 : 329-340.

13) Sances G, et al. Naproxen sodium in menstrual migraine prophylaxis : A double-blind placebo controlled study. Headache 1990 ; 30 : 705-709.

14) 五十嵐久佳. 性成熟期女性における月経関連片頭痛の実態調査. 新薬と治療 2009 ; 58 : 27-36.

P.139 掲載の参考文献

1) 佐藤孝道. 胎児・新生児への薬剤の影響とその区分. 佐藤孝道ほか (編), 実践妊娠と薬-1,173例の相談事例とその情報. 東京 : 薬業時報社 ; 1992, pp.8-13.

2) 日本頭痛学会バルプロ酸による片頭痛治療ガイドライン (暫定版) 委員会. バルプロ酸による片頭痛治療ガイドライン (暫定版). http://jhsnet.org/bpgl_20110329.html

3) MacGregor EA. Migraine in pregnancy and lactation : A clinical review. J Fam Plann Reprod Health Care 2007 ; 33 : 83-93.

4) Sances G, et al. Course of migraine during pregnancy and postpartum : A prospective study. Cephalalgia 2003 ; 23 : 197-205.

5) 日本頭痛学会 (編). 慢性頭痛の診療ガイドライン. 東京 : 医学書院 ; 2006.

6) 独立行政法人国立成育医療研究センター. ママのためのお薬情報. http://www.ncchd.go.jp/kusuri/lactation/druglist.html

7) Evans EW, Lorber KC. Use of 5-HT1 agonists in pregnancy. Ann Pharmacother 2008 ; 42 : 543-549.

8) 五十嵐久佳. 妊娠中, 授乳中の片頭痛患者の治療はどうするか. 岡本幸市ほか (編), EBM神経疾患の治療 2009-2010. 東京 : 中外医学社 ; 2009, pp.624-628.

9) Amecican Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001 ; 108 : 776-789.

10) World Health Organization. Breastfeeding and maternal medication. Recommendations for drugs in the eleventh WHO model list of essential drugs. WHO ; 2003, pp.1-35.

P.144 掲載の参考文献

1) 竹島多賀夫ほか. 片麻痺性片頭痛の全国疫学調査. 日本内科学会誌 2006 ; 95 Supple : 162.

2) Joutel A, et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 1993 ; 5 : 40-45.

3) Ophoff RA, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996 ; 87 : 543-552.

4) De Fusco M, et al. Haploinsufficiency of ATP1A2 encoding the Na+ / K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003 ; 33 : 192-196.

5) Dichgans M, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005 ; 366 : 371-377.

6) Artto V, et al. Treatment of hemiplegic migraine with triptans. Eur J Neurol 2007 ; 14 : 1053-1056.

7) Russell MB, Ducros A. Sporadic and familial hemiplegic migraine : Pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 2011 ; 10 : 457-470.

P.148 掲載の参考文献

1) Kirchmann M, et al. Basilar-type migraine : Clinical, epidemiologic, and genetic features. Neurology 2006 ; 66 : 880-886.

2) Kaniecki RG. Basilar-type migraine. Cur Pain Headache Rep 2009 ; 13 : 217-220.

3) Lewis D, Paradiso E. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children : A pilot study. Headache 2007 ; 47 : 1409-1417.

IV. 緊張型頭痛

P.159 掲載の参考文献

1) 北川泰久. 緊張型頭痛のメカニズム─末梢性から中枢性因子へ. 日本頭痛学会誌 2008 ; 35 : 1-7.

2) Bezov D, et al. Pain perception studies in tension-type headache. Headache 2011 ; 51 : 262-271.

3) Horikawa M, et al. Non-invasive measurement method for hardness in muscular tissues. Med Biol Eng Comput 1993 ; 31 : 623-627.

4) Sakai F, et al. Pericranial muscle hardness in tension-type headache. A non-invasive measurement method and its clinical application. Brain 1995 ; 118 : 523-531.

5) Ashina M, et al. Muscle hardness in patients with chronic tension-type headache : Relation to actual headache state. Pain 1999 ; 79 : 201-205.

6) Jensen R. Pathophysiological mechanisms of tension-type headache : A review of epidemiological and experimental studies. Cephalalgia 1999 ; 19 : 602-621.

7) Ashina M, et al. In vivo evidence of altered skeletal muscle blood flow in chronic tension-type headache. Brain 2002 ; 125 : 320-326.

8) Fernandez-de-las-Penas C, et al. Myofascial trigger points and sensitization : An updated pain model for tension-type headache. Cephalalgia 2007 ; 27 : 383-393.

9) Fumal A, Schoenen J. Tension-type headache : Current research and clinical management. Lancet Neurol 2008 ; 7 : 70-83.

10) Bendtsen L. Central sensitization in tension-type headache--Possible pathophysiological mechanisms. Cephalalgia 2000 ; 20 : 486-508.

11) Jensen R, et al. Muscle tenderness and pressure pain thresholds in headache. A population study. Pain 1993 ; 53 : 193-199.

12) Bendtsen L, et al. Decreased pain detection and tolerance thresholds in chronic tensiontype headache. Arch Neurol 1996 ; 53 : 373-376.

13) Ashina S, et al. Generalized hyperalgesia in patients with chronic tension-type headache. Cephalalgia 2006 ; 26 : 940-948.

14) Mork H, et al. Possible mechanisms of pain perception in patients with episodic tensiontype headache. A new experimental model of myofascial pain. Cephalalgia 2004 ; 24 : 466-475.

15) Schoenen J. Exteroceptive suppression of temporalis muscle activity in patients with chronic headache and normal volunteers : Methodology, clinic and pathophysiological relevance. Headache 1993 ; 33 : 3-17.

16) Langemark M, et al. Decreased nociceptive flexion reflex threshold in chronic tensiontype headache. Arch Neurol 1993 ; 50 : 1061-1064.

17) Ashina M, et al. Nitric oxide-induced headache in patients with chronic tension-type headache. Brain 2000 ; 123 : 1830-1837.

18) Ashina M, et al. Possible machanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache. Brain 1999 ; 122 : 1629-1635.

19) Bendtsen L, Jensen R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headach. Cephalalgia 2000 ; 20 : 603-610.

20) Schmidt-Wilcke T, et al. Gray matter decrease in patients with chronic tension-type headache. Neurology 2005 ; 65 : 1483-1486.

P.162 掲載の参考文献

1) Headache sublassification Subcommittee of the International Headache Society. The International Classification of Headache Disorders : 2nd edition. Cephalalgia 2004 ; 24 (Suppl 1) : 19-160.

2) Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 ; 8 (Suppl 7) : 1-96.

3) 平田幸一ほか. 緊張型頭痛の治療. 鈴木則宏 (編), 頭痛診療ハンドブック. 東京 : 中外医学社 ; 2009, pp.148-161.

P.168 掲載の参考文献

1) Headache Classification Subcommittee of the International Headache Society, The International Classification of Headache Disorders : 2nd edition. Cephalalgia 2004 ; 24 : 9-160.

2) 平田幸一. 緊張型頭痛. 日本頭痛学会誌 2005 ; 32 : 13-17.

3) Rasmussen BK, et al. A population-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia 1991 ; 11 : 129-134.

4) Mongini F, et al. Confirmation of the distinction between chronic migraine and chronic tension-type headache by the McGill Pain Questionnaire. Headache 2003 ; 43 : 867-877.

5) Rasmussen BK, et al. Interrelations between migraine and tension-type headache in the general population. Arch Neurol 1992 ; 49 : 914-918.

6) Spierings EL, et al. Precipitating and aggravating factors of migraine versus tensiontype headache. Headache 2001 ; 41 : 554-558.

7) Rasmussen BK. Migraine and tension-type headache in a general population : Precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 1993 ; 53 : 65-72.

8) Bruni O, et al. Prevalence of sleep disorders in childhood and adolescence with headache : A case-control study. Cephalalgia 1997 ; 17 : 492-498.

9) Bigal ME, et al. Chronic daily headache in a tertiary care population : Correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache. Cephalalgia 2002 ; 22 : 432-438.

10) Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006 ; 26 : 742-746.

11) Langemark M, et al. Clinical characterization of patients with chronic tension headache. Headache 1988 ; 28 : 590-596.

P.171 掲載の参考文献

1) Headache Classification Subcommittee of the International headache Society. The International Classification of Headache Disorders : 2nd edition. Cephalalgia 2004 ; 24 (Suppl 1) : 9-160.

2) Silberstein SD, et al. Classification of daily and near-daily headaches : Field trial of revised IHS criteria. Neurology 1996 ; 47 : 871-875.

3) Headache Classification Committee, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006 ; 26 : 742-746.

4) Puca F, et al. Psychiatric comorbidity and psychosocial stress in patients with tensiontype headache from headache centers in Italy. The Italian Collaborative Group for the Study of Psychopathological Factors in Primary Headaches. Cephalalgia 1999 ; 19 : 159-164.

5) Beghi E, et al. Headache and anxiety-depressive disorder comorbidity : The HADAS study. Neurol Sci 2007 ; 28 (Suppl 2) : S217-219.

6) Mathew NT, et al. Transformation of episodic migraine into daily headache : Analysis of factors. Headache 1982 ; 22 : 66-68.

7) Mathew NT. Transformed migraine, analgesic rebound, and other chronic daily headaches. Neurol Clin 1997 ; 15 : 167-186.

● Winter AC, et al. Association between lifestyle factors and headache. J Headache Pain 2011 ; 12 : 147-155.

P.175 掲載の参考文献

1) 慢性頭痛治療ガイドライン作成小委員会. 日本神経学会治療ガイドライン慢性頭痛治療ガイドライン. 臨床神経 2002 ; 42 : 330-362.

2) 日本頭痛学会 (編). 慢性頭痛の診療ガイドライン. 東京 : 医学書院 ; 2006.

3) Fogelholm R, Murros K. Tizanidine in chronic tension type headache : A placebo controlled double-blind cross-over study. Headache 1992 ; 32 : 509-513.

4) Murros K, et al. Modified-release formulation of tizanidine in chronic tension-type headache. Headache 2000 ; 40 : 633-637.

5) Hirata K, et al. Multi-center randomized control trial of etizolam plus NSAID combination for tension-type headache. Internal Med 2007 ; 46 : 467-472.

6) Gobel H, et al. Chronic tension-type headache : Amitriptyline reduced clinical headacheduration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain 1994 ; 59 : 241-249.

7) Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004 ; 62 : 1706-1711.

8) Silberstein SD, et al. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache : A multicentre, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia 2006 ; 26 : 790-800.

9) Packman E, et al. Lumiracoxib is effective in the treatment of episodic tension-type headache. Headache 2005 ; 45 : 1163-1170.

10) Lampl C, et al. A prospective, controlled, open-label, long-term study of efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache. Cephalalgia 2006 ; 26 : 1203-1208.

11) Fumal A, Schoenen J. Tension-type headache : Current research and clinical management. Lancet Neurol 2008 ; 7 : 70-83.

12) 平田幸一. 緊張型頭痛の病態と治療. 日医雑誌 2008 ; 136 : 2191-2195

P.179 掲載の参考文献

1) 平田幸一ほか. 緊張型頭痛の治療. 鈴木則宏 (編), 頭痛診療ハンドブック. 東京 : 中外医学社 ; 2009, pp.148-161.

2) 平田幸一. 治療法のコツ. 平田幸一ほか (編), 症例から学ぶ戦略的片頭痛診断・治療. 東京 : 南山堂 ; 2010, pp. 238-244.

3) 作田学. 緊張型頭痛の実際. 日内会誌 2001 ; 90 : 74-77.

4) 坪井康次ほか. 頭痛のバイオフィードバック療法. 心身医療 1996 ; 8 : 1321-1324.

P.185 掲載の参考文献

1) Featherstone HJ. Migraine and muscle contraction headaches : A continuum. Headache 1985 ; 25 : 194-198.

2) 竹島多賀夫, 中島健二. 血管性頭痛と緊張型頭痛の一元論. 臨床医1996 ; 22 (12) : 2624-2627.

3) 竹島多賀夫. 緊張型頭痛と片頭痛の関係-合併 vs 一元論. 坂井文彦 (編). 頭痛診療のコツと落とし穴. 東京 : 中山書店 ; 2003, pp.45-47.

4) Messinger HB, et al. Overlap of migraine and tension-type headache in the International Headache Society classification. Cephalalgia 1991 ; 11 : 233-237.

5) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

6) Olesen J, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006 ; 26 (6) : 742-746.

7) 竹島多賀夫ほか, 日本頭痛学会・新国際頭痛分類普及委員会. 慢性片頭痛と薬物乱用頭痛の付録診断基準の追加について. 日本頭痛学会誌 2007 ; 34 (2) : 192-193.

8) 日本頭痛学会 (編). 慢性頭痛の診療ガイドライン. 東京 : 医学書院 ; 2006.

9) 竹島多賀夫ほか. 片頭痛の予防療法. Progress in Medicine 2007 ; 27 : 47-50.

10) 竹島多賀夫. メタボリックシンドローム治療による片頭痛の予防. Brain and Nerve 2009 ; 61 (10) : 1143-1153.

11) Takeshima T, Takahashi K. The relationship between muscle contraction headache and migraine : A multivariate analysis study. Headache 1988 ; 28 (4) : 272-277.

12) Cady RK. The convergence hypothesis. Headache 2007 ; 47 (Suppl 1) : S44-S51.

13) 竹島多賀夫. 薬物乱用頭痛, 慢性連日性頭痛 (慢性片頭痛, 変容片頭痛, 慢性緊張型頭痛). 鈴木則宏 (編), 頭痛診療ハンドブック. 東京 : 中外医学社 ; 2009, pp.200-224.

V. 群発頭痛

P.191 掲載の参考文献

1) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

2) 今井昇. 群発頭痛の病態・治療の最近のトピックス─治療の実際とノウハウは? Medicina 2006 ; 43 : 1850-1852.

3) 今井昇. 群発頭痛の中枢神経の機能異常. Clin Neurosci 2007 ; 25 : 586-587.

4) 根来清. 群発頭痛の病態・治療の最近のトピックス. 診断と治療 2007 ; 95 : 587-591.

5) Leone M, Bussone G. A review of hormonal findings in cluster headache. Evidence for hypothalamic involvement. Cephalalgia 1993 ; 13 : 309-317.

6) Leone M, et al. Twenty-four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalalgia 1995 ; 15 : 224-229.

7) May A, et al. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med 1999 ; 5 : 836-838.

8) May A, et al. Hypothalamic activation in cluster headache attacks. Lancet 1998 ; 352 : 275-278.

9) Wang SJ, et al. Reduction in hypothalamic 1H-MRS metabolite ratios in patients with cluster headache. J Neurol Neurosurg Psychiatry 2006 ; 77 : 622-625.

10) Lodi R, et al. Study of hypothalamic metabolism in cluster headache by proton MR spectroscopy. Neurology 2006 ; 66 : 1264-1266.

11) Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 1994 ; 117 : 427-434.

12) 永田栄一郎ほか. 群発頭痛における血管作動性物質について. 日本頭痛学会誌 1996 ; 23 : 21-23.

13) Steinberg A, et al. Levels of nitric oxide metabolites in cerebrospinal fluid in cluster headache. Cephalalgia 2010 ; 30 : 696-702.

14) Lieba-Samal D, Wober C. Sexhormones and primary headaches other than migraine. Curr Pain Headache Rep 2011, May 15. [Epub ahead of print].

15) Schurks M. Genetics of cluster headache. Curr Pain Headache Rep 2010 ; 14 : 132-139.

16) Suzuki N, Hardebo JE. Anatomical basis for a parasympathetic and sensory innervations of the intracranial segment of the internal carotid artery in man. J Neurol Sci 1991 ; 104 : 19-31.

17) May A. Cluster headache : Pathogenesis, diagnosis, and management. Lancet 2005 ; 366 : 843-855.

P.206 掲載の参考文献

1) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

2) Imai N, et al. Clinical profile of cluster headaches in Japan : Low prevalence of chronic cluster headache, and uncoupling of sense and behaviour of restlessness. Cephalalgia 2011 ; 31 : 628-633.

3) Cohen AS, et al. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA) --a prospective clinical study of SUNCT and SUNA. Brain 2006 ; 129 : 2746-2760.

4) 日本頭痛学会 (編). 慢性頭痛の診療ガイドライン. 東京 : 医学書院 ; 2006.

5) May A, et al. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol 2006 ; 13 : 1066-1077.

6) Francis GJ, et al. Acute and preventive pharmacologic treatment of cluster headache. Neurology 2010 ; 75 : 463-473.

● May A. Cluster headache : Pathogenesis, diagnosis, and management. Lancet 2005 : 366 : 843-855.

● Ashkenazi A, Schwedt T. Cluster headache--acute and prophylactic therapy. Headache 2011 ; 51 : 272-286.

VI. 薬物乱用頭痛, 慢性連日性頭痛

P.217 掲載の参考文献

1) Diener H-C, Limmroth V. Medication-overuse headache : A worldwide problem. Lancet Neurol 2004 ; 3 : 475-483.

2) Paemeleire K, et al. Medication-overuse headache in patients with cluster headache. Neurology 2006 ; 67 : 109-113.

3) Dawson AJ, et al. Medication-overuse headache in patients with primary headache disorders : Epidemiology, management and pathogenesis. CNS Drugs 2005 ; 19 : 483-497.

4) Supornsilpchai W, et al. Cortical hyperexcitability and mechanism of medicationoveruse headache. Cephalalgia 2010 ; 30 : 1101-1109.

5) De Felice M, et al. Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers. Brain 2010 ; 133 (Pt 8) : 2475-2488.

6) Fuh JL, et al. Does medication overuse headache represent a behavior of dependence. Pain 2005 ; 119 : 49-55.

7) Radat F, et al. Behavioral dependence in patients with medication overuse headache : A cross-sectional study in consulting patients with DMS-IV criteria. Headache 2008 ; 48 : 1026-1036.

8) Calabresi P, Cupini LM. Medication-overuse headache : Similarities with drug addiction. Trends Pharmacol Sci 2005 ; 26 : 62-68.

9) Fumal A, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 2006 ; 129 : 543-550.

10) Di Lorenzo C, et al. Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism. J Headache Pain 2009 ; 10 : 349-355.

11) Sarchielli P, et al. Endocannabinoids in chronic migraine : CSF findings suggest a system failure. Neuropsychopharmacology 2007 ; 32 : 1384-1390.

12) Sarchelli P, et al. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache : Findings from cerebrospinal fluid. Cephalalgia 2008 ; 28 : 714-722.

13) Bφe MG, et al. Prednisolone does not reduce withdrawal headache : A randomized double-blind study. Neurology 2007 ; 69 : 26-31.

14) Trucco M, et al. Medication overuse headache : Withdrawal and prophylactic therapeutic regimen. Headache 2010 ; 50 : 989-997.

15) Katsarava Z, et al. Medication overuse headache : Rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005 ; 25 : 12-15.

P.222 掲載の参考文献

1) Welch KM, et al. Periaqueductal gray matter dysfunction in migraine : Cause or the burden of illness? Headache 2001 ; 41 : 629-637.

2) Hershey AD, et al. Genomic expression patterns in medication overuse headaches. Cephalalgia 2011 ; 31 : 161-171.

3) Diener H-C, et al ; PREEMPT 2 Chronic Migrane Study Group. OnabotulinumtoxinA for treatment of chronic migraine : Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 2010 ; 30 : 804-814.

4) Scher AI, et al. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003 ; 106 : 81-89.

VII. 小児・思春期の頭痛

P.227 掲載の参考文献

1) Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004 ; 24 (Suppl 1) : 9-160.

2) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

3) Abu-Arafeh I, et al. Prevalence of headache and migraine in children and adolescents : A systematic review of population-based studies. Dev Med Child Neurol 2010 ; 52 : 1088-1097.

4) Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 ; 8 (Suppl 7) : 1-96.

5) Ando N, et al. Prevalence and features of migraine in Japanese junior high school students aged 12-15 yr. Brain Dev 2007 ; 29 : 482-485.

6) Stovner LJ, Andree C. Prevalence of headache in Europe : A review for the Eurolight project. J Headache Pain 2010 ; 11 : 289-299.

7) Lewis DW. Pediatric migraine. Neurol Clin 2009 ; 27 : 481-501.

8) 安藤直樹ほか. 当院頭痛外来を受診した小児頭痛の分類と特徴. 日本頭痛学会誌 2010 ; 37 : 6-8.

9) 藤田光江ほか. 小児慢性反復性頭痛の研究第4編-一般小児科から他科へ依頼する頭痛. 日児誌 2001 ; 105 : 576-583.

P.235 掲載の参考文献

1) Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004 ; 24 (Suppl 1) : 9-160.

2) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

3) 藤田光江. 子供の頭痛の診かた. 日本頭痛学会誌 2010 ; 37 : 76-81.

4) 藤田光江ほか. 小児片頭痛における家族集積性の検討. 日本頭痛学会誌 2010 ; 36 : 239-243.

5) Kossoff EH, Andermann F. Migraine and epilepsy. Semin Pediatr Neurol 2010 ; 17 : 117-122.

6) Toldo I, et al. Comorbidity between headache and epilepsy in a pediatric headache center. J Headache Pain 2010 ; 11 : 235-240.

7) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981 ; 22 : 489-501.

8) Parisi P. Why is migraine rarely, and not usually, the sole ictal epileptic manifestation? Seizure 2009 ; 18 : 309-312.

9) Seshia SS, et al. Chronic daily headache in children and adolescents : A multi-faceted syndrome Can J Neurol Sci 2010 ; 37 : 769-778.

10) 安藤直樹ほか. 当院頭痛外来を受診した小児頭痛の分類と特徴. 日本頭痛学会誌 2010 ; 37 : 6-8.

11) 藤田光江. 小児の頭痛の特徴と重要性. 五十嵐隆 (総編), 小児科臨床ピクシス 12, 小児の頭痛診かた治しかた. 東京 : 中山書店 ; 2009, pp.2-3.

12) 田中英高ほか. 小児起立性調節障害診断・治療ガイドライン. 日本小児心身医学会 (編), 小児心身医学会ガイドライン集-日常診療に活かす4つのガイドライン. 東京 : 南江堂 ; 2009, pp.2-54.

P.239 掲載の参考文献

1) 藤田光江. 子供の頭痛の診かた. 日本頭痛学会誌 2010 ; 37 : 76-81.

2) Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004 ; 24 (Suppl 1) : 19-160.

3) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

4) 藤田光江. 小児頭痛診療のポイント. 日本医師会雑誌 2008 ; 136 : 2213-2216.

P.249 掲載の参考文献

1) Lewis DW. Pediatric migraine. Neurol Clin 2009 ; 27 : 481-501.

2) Parisi P, et al. Tension-type headache in paediatric age. Acta Paediatr 2011 ; 100 : 491-495.

3) Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004 ; 24 (Suppl 1) : 1-160.

4) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

5) Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981 ; 22 : 489-501.

VIII. その他の一次性頭痛

P.254 掲載の参考文献

1) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007, pp.32-38.

2) Rasmussen BK, Olesen J. Symptomatic and nonsymptomatic headaches in a general population. Neurology 1992 ; 42 : 1225-1231.

3) Sjaastad O, et al. The Vaga study ; Epidemiology of headache Ι : The prevalence of ultrashort paroxysms. Cephalalgia 2001 ; 21 : 207-215.

4) Fuh JL, et al. Primary stabbing headache in a headache clinic. Cephalalgia 2007 ; 27 : 1005-1009.

5) 手塚博幸. Idiopathic stabbing headache. 神経内科 1997 ; 47 : 245-250.

6) Pareja JA, et al. Idiopathic stabbing headache (jabs and jolts syndrome). Cephalalgia 1996 ; 16 : 93-96.

7) Ferrante E, et al. Focus on therapy of primary stabbing headache. J Headache Pain 2010 ; 11 : 157-160.

8) Piovesan EJ, et al. Botulinum neurotoxin type-A for primary stabbing headache : An open study. Arq Neuropsiquiatr 2010 ; 68 : 212-215.

9) Selekler HM, Budak F. Idiopathic stabbing headache and experimental ice cream (short-lived headaches). Eur Neurol 2004 ; 51 : 6-9.

● Wang SJ, Fuh JL. The "other" headaches : Primary cough, exertion, sex, and primary stabbing headaches. Curr Pain Headache Rep 2010 ; 14 : 41-46.

P.257 掲載の参考文献

1) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007, pp.32-38.

2) Pascual J. Primary cough headache. Curr Pain Headache Rep 2005 ; 9 : 272-276.

3) Chen P-K, et al. Cough headache : A study of 83 consecutive patients. Cephalalgia 2009 ; 29 : 1079-1085.

4) Rasmussen BK, Olesen J. Symptomatic and nonsymptomatic headaches in a general population. Neurology 1992 ; 42 : 1225-1231.

5) Ozge C, et al. Cough headache : Frequency, characteristics and the relationship with the characteristics of cough. Eur J Pain 2005 ; 9 : 383-388.

6) Wang SJ, Fuh JL. The "other" headaches : Primary cough, exertion, sex, and primary stabbing headaches. Curr Pain Headache Rep 2010 ; 14 : 41-46.

7) Raskin NH. Short-lived head pains. Neurol Clin 1997 ; 15 : 143-152.

8) Chen YY, et al. Primary cough headache is associated with posterior fossa crowdedness : A morphometric MRI study. Cephalalgia 2004 ; 24 : 694-699.

9) Wang SJ, et al. Benign cough headache is responsive to acetazolamide. Neurology 2000 ; 55 : 149-150.

10) Boes CJ, et al. Benign cough headache. Cephalagia 2002 ; 22 : 772-779.

P.259 掲載の参考文献

1) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007, pp.32-38.

2) Pascual J, et al. Cough, exertional, and sexual headaches : An analysis of 72 benign and symptomatic cases. Neurology 1996 ; 46 : 1520-1524.

3) Rasmussen BK, Olesen J. Symptomatic and nonsymptomatic headaches in a general population. Neurology 1992 ; 42 : 1225-1231.

4) Sjaastad O, Bakketeig LS. Exertional headache. I. Vaga study of headache epidemiology. Cephalalgia 2002 ; 22 : 784-790.

5) Chen SP, et al. Exertional headache--A survey of 1963 adolescents. Cephalalgia 2009 ; 29 : 401-407.

6) Sjaastad O, Bakketeig LS. Exertional headache - II. Clinical features Vaga study of headache epidemiology. Cephalalgia 2003 ; 23 : 803-807.

7) Olesen J. The future of headache classification and classification research. Cephalalgia 2009 ; 29 : 1240-1241.

8) Lipton RB, et al. Cardiac cephalalgia : A treatable form of exertional headache. Neurology 1997 ; 49 : 813-816.

9) Sathirapanya P. Anginal cephalalgia : A serious form of exertional headache. Cephalalgia 2004 ; 24 : 231-234.

10) Diamond S. Prolonged benign exertional headache : Its clinical characteristics and response to indomethacin. Headache 1982 ; 22 : 96-98.

11) 池田憲ほか. Propranolol hydrochlorideによる一次性労作性頭痛の予防効果-indometacinとの比較. 神経治療学 2008 ; 25 : 605-608.

P.262 掲載の参考文献

1) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007, pp. 32-38.

2) Rasmussen BK, Olesen J. Symptomatic and nonsymptomatic headaches in a general population. Neurology 1992 ; 42 : 1225-1231.

3) Frese A, et al. Headache associated with sexual activity : Demography, clinical features, and comorbidity. Neurology 2003 ; 61 : 796-800.

4) Yeh YC, et al. Clinical features, imaging findings and outcomes of headache associated with sexual activity. Cephalalgia 2010 ; 30 : 1329-1335.

5) Turner IM, Harding TM. Headache and sexual activity : A review. Headache 2008 ; 48 : 1254-1256.

6) Evers S, et al. The cerebral hemodynamics of headache associated with sexual activity. Pain 2003 ; 102 : 73-78.

7) Frese A, et al. Headache associated with sexual activity : Prognosis and treatment options. Cephalalgia 2007 ; 27 : 1265-1270.

8) Silbert PL, et al. Benign vascular sexual headache and exertional headache : Interrelationships and long term prognosis. J Neurol Neurosurg Psychiatry 1991 ; 54 : 417-421.

P.264 掲載の参考文献

1) Raskin NH. The hypnic headache syndrome. Headache 1988 ; 28 : 534-536.

2) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007, pp.32-38.

3) Dodick DW, et al. The hypnic ("alarm clock") headache syndrome. Cephalalgia 1998 ; 18 : 152-156.

4) Liang JF, et al. Clinical features, polysomnography and outcome in patients with hypnic headache. Cephalalgia 2008 ; 28 : 209-215.

5) 福原葉子ほか. 睡眠時頭痛 (hypnic headache) の本邦3症例. 臨床神経学 2006 ; 46 : 148-153.

6) Evers S, Goadsby PJ. Hypnic headache : Clinical features, pathophysiology, and treatment. Neurology 2003 ; 60 : 905-909.

7) Donnet A, Lanteri-Minet M. A consecutive series of 22 cases of hypnic headache in France. Cephalalgia 2009 ; 29 : 928-934.

8) De Simone R, et al. Hypnic headache : An update. Neurol Sci 2006 ; 27 (Suppl 2) : S144-S148.

9) Holle D, et al. Serial polysomnography in hypnic headache. Cephalalgia 2011 ; 31 : 286-290.

10) Holle D, et al. Hypothalamic gray matter volume loss in hypnic headache. Ann Neurol 2011 ; 69 : 533-539.

11) Holle D, et al. Clinical characteristics and therapeutic options in hypnic headache. Cephalalgia 2010 ; 30 : 1435-1442.

● Lanteri-Minet M, Donnet A. Hypnic headache. Curr Pain Headache Rep 2010 ; 14 : 309-315.

P.268 掲載の参考文献

1) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007. pp.32-38.

2) Koopman K, et al. An often unrecognized cause of thunderclap headache : Reversible cerebral vasoconstriction syndrome. J Headache Pain 2008 ; 9 : 389-391.

3) Broner S, et al. Thunderclap headache as the presenting symptom of myocardial infarction. Headache 2007 ; 47 : 724-725.

4) Heo YE, et al. Thunderclap headache as an initial manifestation of phaeochromocytoma. Cephalalgia 2008 ; 29 : 388-390.

5) Schwedt TJ, et al. Thunderclap headache. Lancet Neurol 2006 ; 5 : 621-631.

6) Chen SP, et al. Reccurent primary thunderclap headache and benign CNS angiopathy : Spectra of the same disorder? Neurology 2006 ; 67 : 2164-2169.

7) Negoro K, et al. Benign hot bath related headache. Headache 2000 ; 40 : 173-175.

8) Liao YC, et al. Bathing headache : A variant of idiopathic thunderclap headache. Cephalalgia 2003 ; 23 : 854-859.

9) Wang SJ, et al. Bath-related thunderclap headache : A study of 21 consecutive patients. Cephalalgia 2008 ; 28 : 524-530.

P.271 掲載の参考文献

1) Sjaastad O, Spierings ELH. "Hemicrania continua" : Another headache absolutely responsive to indomethacin. Cephalalgia 1984 ; 4 : 65-70.

2) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007, pp.32-38.

3) 石崎公郁子ほか. Hemicrania continuaの1例-本邦第1例. 臨床神経学 2002 ; 42 : 754-756.

4) Peres MF, et al. Hemicrania continua is not that rare. Neurology 2001 ; 57 : 948-951.

5) Cittadini E, Goadsby PJ. Hemicrania continua : A clinical study of 39 patients with diagnostic implications. Brain 2010 (PT 7) ; 133 : 1973-1986.

6) Marmura MJ, et al. Hemicrania continua : Who responds to indomethacin? Cephalalgia 2009 ; 29 : 300-307.

7) Castellanous-Pinedo F, et al. Hemicrania continua evolving from episodic paroxysmal hemicrania. Cephalalgia 2006 ; 26 : 1143-1145.

8) 斎藤義朗ほか. 群発頭痛の経過中に持続性片側頭痛 (hemicrania continua) に移行した1例. 臨床神経学 2005 ; 45 : 250-252.

9) Schwedt TJ, et al. Occipital nerve stimulation for chronic cluster headache and hemicrania continua : Pain relief and persistence of autonomic features. Cephalalgia 2006 ; 26 : 1025-1027.

10) Matharu MS, et al. Posterior hypothalamic and brainstem activation in hemicrania continua. Headache 2004 ; 44 : 747-761.

11) Pareja JA, et al. Dose, efficacy and tolerability of long-term indomethacin treatment of chronic paroxysmal hemicrania and hemicrania continua. Cephalalgia 2001 ; 21 : 906-910.

12) Brighina F, et al. Prophylaxis of hemicranias continua : Two new cases effectively treated with topiramate. Headache 2007 ; 47 : 441-443.

13) Spears RC. Is gabapentin an effective treatment choice for hemicranias continua? J Headache Pain 2009 ; 10 : 271-275.

14) Nicpon KJ, et al. Prophylaxis of hemicranias continua : Three cases effectively treated with acemethacin. Cephalalgia 2011 ; 31 : 625-627.

15) Burns B, et al. Treatment of hemicrania continua by occipital nerve stimulation with a bion device : Long term follow up of a crossover study. Lancet Neurol 2008 ; 7 : 1001-1012.

● Cittadini E, Goadsby PJ. Update on hemicrania continua. Curr Pain Headache Rep 2011 ; 15 : 51-56

P.273 掲載の参考文献

1) Vanast WJ. New daily persistent headaches definition of a benign syndrome. Headache 1986 ; 26 : 318.

2) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007, pp.32-38.

3) 高瀬靖ほか. 一次性new daily persistent headacheの臨床的検討-43例の発症様式, 誘因, 発症年齢, 男女比, 頭痛の性状, 頻度について. 臨床神経学 2003 ; 43 : 533-538.

4) Grande RB, et al. Prevalence of new daily persistent headache in the general population. The Akershus study of chronic headache. Cephalalgia 2009 ; 29 : 1149-1155.

5) Rozen TD. New daily persistent headache. Curr Opin Neurol 2011 ; 24 : 211-216.

6) Li D, Rozen TD. The clinical characteristics of new daily persistent headache. Cephalalgia 2002 ; 22 : 66-69.

7) Robbins MS, et al. Clinical and prognostic subforms of new daily-persistent headache. Neurology 2010 ; 74 : 1358-1364.

8) Diaz-Mitoma F, et al. Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches. Lancet 1987 ; 1 : 411-415.

9) Goadsby PJ. New daily persistent headache : A syndrome not a discrete disorder. Headache 2011 ; 51 : 650-653.

10) Rozen TD. Successful treatment of new daily persistent headache with gabapentin and topiramate. Headache 2002 ; 42 : 433.

11) Evans RW, Rozen TD. Etiology and treatment of new daily persistent headache. Headache 2001 ; 41 : 830-832.

IX. 頭部神経痛および中枢性顔面痛

P.279 掲載の参考文献

1) Manzoni GC, Torelli P. Epidemiology of typical and atypical craniofacial neuralgias. Neurol Sci 2005 ; 26 (Suppl 2) : s65-67.

2) Katusic S, et al. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol 1990 ; 27 : 89-95.

3) Cheng TM, et al. Comprehensive study of diagnosis and treatment of trigeminal neuralgia secondary to tumors. Neurology 1993 ; 43 : 2298-2302.

4) Love S, Coakham HB. Trigeminal neuralgia : Pathology and pathogenesis. Brain 2001 ; 124 : 2347-2360.

5) Nurmikko TJ, Eldridge PR. Trigeminal neuralgia--pathophysiology, diagnosis and current treatment. Br J Anaesth 2001 ; 87 : 117-132.

6) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007, pp.123-124.

7) Cruccu G, et al. American Academy of Neurology Society ; European Federation of Neurological Society. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 2008 ; 15 : 1013-1028.

8) Krafft RM. Trigeminal neuralgia. Am Fam Physician 2008 ; 77 : 1291-1296.

9) Jorns TP, Zakrzewska JM. Evidence-based approach to the medical management of trigeminal neuralgia. Br J Neurosurg 2007 ; 21 : 253-261.

10) 日本神経治療学会治療指針作成委員会. 標準的神経治療-三叉神経痛. 神経治療学 2010 ; 27 : 105-132.

P.281 掲載の参考文献

1) Teixeira MJ, et al. Glossopharyngeal neuralgia : Neurosurgical treatment and differential diagnosis. Acta Neurochir (Wien) 2008 ; 150 (5) : 471-475.

2) Evans RW, et al. Glossopharyngeal neuralgia. Headache 2006 ; 46 (7) : 1200-1202.

3) Pearce JM. Glossopharyngeal neuralgia. Eur Neurol 2006 ; 55 (1) : 49-52.

4) Sadosky A, et al. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract 2008 ; 8 (1) : 45-56.

5) Rozen TD. Trigeminal neuralgia and glossopharyngeal neuralgia. Neurol Clin 2004 ; 22 (1) : 185-206.

6) Benoliel R, Eliav E. Neuropathic orofacial pain. Oral Maxillofac Surg Clin North Am 2008 ; 20 (2) : 237-254.

7) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007, p.124.

8) Kandan SR, et al. Neuralgia of the glossopharyngeal and vagal nerves : Long-term outcome following surgical treatment and literature review. Br J Neurosurg 2010 ; 24 (4) : 441-446.

9) Kim E, et al. Eagle syndrome : Case report and review of the literature. Ear Nose Throat J 2008 ; 87 (11) : 631-633.

10) Shin JH, et al. Entrapment of the glossopharyngeal nerve in patients with Eagle syndrome : Surgical technique and outcomes in a series of 5 patients. J Neurosurg 2009 ; 111 (6) : 1226-1230.

P.285 掲載の参考文献

1) Vanelderen P, et al. Occipital neuralgia. Pain Pract 2010 ; 10 (2) : 137-144.

2) Kuhn WF, et al. Occipital neuralgias : Clinical recognition of a complicated headache. A case series and literature review. J Orofac Pain 1997 ; 11 (2) : 158-165.

3) Anthony M. Headache and the greater occipital nerve. Clin Neurol Neurosurg 1992 ; 94 : 297-301.

4) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007. p.126.

5) Kapoor V, et al. Refractory occipital neuralgia : Preoperative assessment with CTguided nerve block prior to dorsal cervical rhizotomy. Am J Neuroradiol 2003 ; 24 : 2105-2110.

6) Merskey J, et al (editors). Classification of Chronic Pain : Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. Washington, USA : International Association for the Study of Pain ; 1994, pp.59-68.

7) Vogel P. Kopfschmerzen mit okzipitalem Schwerpunkt : Zervikal-Syndrom Spannungskopf-schmerz-okzipital Neyralgie. Akt Neurol 1987 ; 14 : 176-178.

8) Gawel MJ, Rothbart PJ. Occipital nerve block in the management of headache and cervical pain. Cephalalgia 1992 ; 12 : 9-13.

Case Study

P.291 掲載の参考文献

1) Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition (ICHD-II). Cephalalgia 2004 ; 24 (Suppl 1) : 1.

2) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

3) 日本頭痛学会 (編). 慢性頭痛の診療ガイドライン. 東京 : 医学書院 ; 2006.

4) Silberstein SD, et al. Topiramate in migraine prevention : Results of a large controlled trial. Arch Neurol 2004 ; 61 : 490-495.

5) Ashtari F, et al. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis. Acta Neurol Scand 2008 ; 118 : 301-305.

6) Dodick DW, et al. Topiramate versus amitriptyline in migraine prevention : A 26-week, multicenter, randomized, double-blind, double-dummy, parallelgroup noninferiority trial in adult migraineurs. Clin Ther 2009 ; 31 : 542-559.

P.296 掲載の参考文献

1) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

2) MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004 ; 63 (2) : 351-353.

3) Granella F, et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 2004 ; 24 : 707-716.

4) Nett R, et al. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine. Obstet Gynecol 2003 ; 102 : 835-842.

5) Silberstein SD, et al. Rizatriptan in the treatment of menstrual migraine. Obstet Gynecol 2000 ; 96 : 237-242.

6) Loder E, et al. Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine : A randomized, prospective, parallel-group, doubleblind, placebo-controlled study. Headache 2004 ; 44 : 120-130.

7) Massiou H, et al. Efficacy of oral naratriptan in the treatment of menstrually related migraine. Eur J Neurol 2005 ; 12 : 774-781.

8) Newman LC, et al. A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology 1998 ; 51 : 307-309.

9) Tuchman M, et al. Oral zolmitriptan 2.5 mg demonstrates high efficacy and good tolerability in the prophylactic treatment of menstrual migraine headaches. Headache 2005 ; 45 : 771-772.

10) Mannix LK, et al. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine : Data from two randomized, double-blind, placebo-controlled studies. Headache 2007 ; 47 : 1037-1049.

11) 五十嵐久佳. 性成熟期女性における月経関連片頭痛の実態調査. 新薬と臨床 2009 ; 58 : 27-36.

P.302 掲載の参考文献

1) Sances G, et al. Course of migraine during pregnancy and postpartum : A prospective study. Cephalalgia 2003 ; 23 : 197-205.

2) 五十嵐久佳. 女性の頭痛 (月経時の片頭痛の診断・治療, 妊娠・授乳中の頭痛治療). 鈴木則宏 (編), 頭痛診療ハンドブック. 東京 : 中外医学社 ; 2009, pp.237-247.

3) 丸山精一ほか. トリプタン製剤を知る (7) 授乳婦がトリプタン製剤を服用している際, 安全に授乳する方法はありますか? 薬局 2007 ; 58 : 2255-2258.

4) 浦部晶夫ほか. 今日の治療薬 2011. 東京 : 南江堂 ; 2011.

5) Hoshiyama E, et al. Pattern of migraine duringpregnancy and postpartum. Cephalalgia 2009 ; 29 : 92 (Abst).

P.313 掲載の参考文献

1) 竹島多賀夫. 薬物乱用頭痛, 慢性連日性頭痛 (慢性片頭痛, 変容片頭痛, 慢性緊張型頭痛). 鈴木則宏ほか, 頭痛診療ハンドブック. 東京 : 中外医学社 ; 2009, pp.200-224.

2) 竹島多賀夫ほか. 慢性片頭痛と薬物乱用頭痛の付録診断基準の追加について. 日本頭痛学会誌 2007 : 34 (2) : 192-193.

3) Bartsch T, Goadsby PJ. The trigeminocervical complex and migraine : Current concepts and synthesis. Curr Pain Headache Rep 2003 ; 7 (5) : 371-376.

P.317 掲載の参考文献

1) 日本頭痛学会・国際頭痛分類普及委員会 (訳). 国際頭痛分類第2版. 新訂増補日本語版. 東京 : 医学書院 ; 2007.

2) Imai N, et al. Clinical profile of cluster headaches in Japan : Low prevalence of chronic cluster headache, and uncoupling of sense and behaviour of restlessness. Cephalalgia 2011 ; 31 : 628-633.

3) 日本頭痛学会 (編). 慢性頭痛の診療ガイドライン. 東京 : 医学書院 ; 2006.

4) May A, et al. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol 2006 ; 13 : 1066-1077.

5) Francis GJ, et al. Acute and preventive pharmacologic treatment of cluster headache. Neurology 2010 ; 75 : 463-473.

P.321 掲載の参考文献

1) Bigal ME, Lipton RB. What predicts the change from episodic to chronic migraine? Curr Opin Neurol 2009 ; 22 : 269-276.

書評

書評を投稿する

最近チェックした商品履歴

Loading...